000 01092 a2200301 4500
005 20250515055135.0
264 0 _c20070404
008 200704s 0 0 eng d
022 _a1699-3993
024 7 _a10.1358/dot.2006.42.12.1025698
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFreemont, A J
245 0 0 _aLanthanum carbonate.
_h[electronic resource]
260 _bDrugs of today (Barcelona, Spain : 1998)
_cDec 2006
300 _a759-70 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aBone and Bones
_xdrug effects
650 0 4 _aClinical Trials as Topic
650 0 4 _aHumans
650 0 4 _aKidney Failure, Chronic
_xcomplications
650 0 4 _aLanthanum
_xpharmacokinetics
650 0 4 _aPhosphates
_xmetabolism
650 0 4 _aPhosphorus Metabolism Disorders
_xdrug therapy
650 0 4 _aTrace Elements
_xpharmacokinetics
773 0 _tDrugs of today (Barcelona, Spain : 1998)
_gvol. 42
_gno. 12
_gp. 759-70
856 4 0 _uhttps://doi.org/10.1358/dot.2006.42.12.1025698
_zAvailable from publisher's website
999 _c16845535
_d16845535